Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OAS3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | RIMBP3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
mRNA | LRRC25 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | DOCK11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | ARL6 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
mRNA | FAM179B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
mRNA | REM2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | SOWAHC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | NEK3 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | GAD2 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |